Dapavas 10mg Tablet
Marketer
Vasu Organics Pvt Ltd
Salt Composition
Dapagliflozin (10mg)
Overview Dapavas 10mg Tablet
Empagliflozin 10mg tablets are prescribed for type 2 diabetes management, either independently or alongside other medications. They regulate elevated blood glucose, mitigating the risk of severe diabetic complications and cardiovascular events. This medication can be administered with or without food, consistently at the same time daily, as determined by your physician. Discontinuation requires medical consultation; otherwise, hyperglycemia and consequential risks such as nephropathy and vision impairment may occur. This treatment complements lifestyle modifications including balanced nutrition, regular physical activity, and weight management, as recommended by your doctor. Common side effects include vaginal yeast infections, upper respiratory infections, and urinary tract infections. Excessive fluid loss is possible; increased fluid intake is advised to prevent dehydration. Practicing good hygiene can minimize genital fungal infections. Prior to commencing treatment, disclose any kidney or liver conditions, urinary tract infections, or diuretic use to your physician. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption to reduce the potential for adverse reactions. Regular blood glucose monitoring is crucial while using this medication.
Primary Ingredients of Dapavas 10mg Tablet
The provided text is "undefined," therefore no rewriting is possible.
Uses of Dapavas 10mg Tablet
Managing type 2 diabetes
Major Benefits of Dapavas 10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Dapavas 10mg Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Dapavas 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapavas 10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not chew, crush, or divide it. Dapavas 10mg Tablets can be taken with or without food, however, consistent timing is recommended.
How Dapavas 10mg Tablet works:
Dapavas 10mg tablets are used to manage diabetes. Their mechanism of action involves eliminating surplus glucose via urinary excretion.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption while taking Dapavas 10mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Dapavas 10mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Using Dapavas 10mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Individuals with kidney impairment should likely refrain from using Dapavas 10mg tablets due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Ten-milligram Dapavas tablets are considered safe for use by individuals with hepatic impairment. No alteration of the Dapavas 10mg tablet dosage is advised.
What if you forget to take Dapavas 10mg Tablet :
Should you forget a Dapavas 10mg Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dapavas 10mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Behavioral Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
3,018 People bought this recently